Denis A, Bretin F, Fromentin C, Bonnet A, Piltan G, Bonnefoy A, Agouridas C
Medicinal Chemistry, Aventis Pharma, Romainville, France.
Bioorg Med Chem Lett. 2000 Sep 4;10(17):2019-22. doi: 10.1016/s0960-894x(00)00392-9.
The effect of 2,3 modifications on the antibacterial activity of ketolides was evaluated by introducing substituents in position 2 and converting the C-1, C-2, C-3 beta-keto-ester into stable 2,3 enol-ether or 2,3 anhydro derivatives. Introduction of a fluorine in C-2 is beneficial with regard to the overall antibacterial spectrum whereas the enol-ether and 2,3 unsaturated compounds, as well as the bulky gem dimethyl or 2-chloro derivatives, are less active particularly against erythromycin resistant strains. A 2-fluoro ketolide derivative demonstrates good antibacterial activity and in vivo efficacy against multi-resistant Streptococcus pneumoniae. Compared to azithromycin against Haemophilus influenzae, this compound is equivalent in vitro and slightly more active in vivo. These results demonstrate that within the ketolide class, to retain good antibacterial activity, position 2 needs to remain tetrahedral and tolerates only very small substituents such as fluorine.
通过在2位引入取代基并将C-1、C-2、C-3β-酮酯转化为稳定的2,3-烯醇醚或2,3-脱水衍生物,评估了2,3修饰对酮内酯类抗菌活性的影响。在C-2位引入氟对整个抗菌谱有益,而烯醇醚和2,3-不饱和化合物,以及庞大的偕二甲基或2-氯衍生物,活性较低,尤其是对耐红霉素菌株。一种2-氟酮内酯衍生物对多重耐药肺炎链球菌显示出良好的抗菌活性和体内疗效。与阿奇霉素对流感嗜血杆菌的作用相比,该化合物在体外相当,在体内活性略高。这些结果表明,在酮内酯类中,为保持良好的抗菌活性,2位需要保持四面体结构,并且只能耐受非常小的取代基,如氟。